Midterm Outcomes of Simultaneous Hybrid Coronary Artery Revascularization for Left Main Coronary Artery Disease
DOI:
https://doi.org/10.1532/HSF98.20111004Abstract
Background: The purpose of this study was to evaluate the feasibility, safety, and midterm outcomes of a simultaneous hybrid revascularization strategy for left main coronary artery disease (LMCAD), compared with conventional off-pump coronary artery bypass grafting (OPCAB).
Methods: We compared the in-hospital and midterm outcomes of a simultaneous hybrid revascularization strategy (minimally invasive direct coronary bypass grafting of the left anterior descending coronary artery [LAD] and percutaneous intervention to non-LAD lesions) in 20 patients with LMCAD in an enhanced operating room. These patients were matched by propensity score to a group of 20 control patients who underwent standard OPCAB between September 2007 and December 2009.
Results: All baseline clinical characteristics of the 2 groups were similar. All of the patients in the 2 groups underwent surgery uneventfully without conversion to on-pump coronary artery bypass grafting. Compared with OPCAB, the patients in the hybrid group had shorter lengths of stay in the intensive care unit (34.8 ± 37.6 hours versus 50.7 ± 34.5 hours, P = .01). Transfusion requirements were reduced in the hybrid patients compared with the OPCAB patients (5% versus 40%, P = .01). The 2 groups did not differ with respect to the occurrence of other important morbidities. During the mean (±SD) follow-up of 18.5 ± 9.8 months, the group of patients who underwent the simultaneous hybrid procedure experienced an incidence of major adverse cardiac or cerebrovascular events that was similar to that of the OPCAB control group (100% versus 90%, respectively; P = .31).
Conclusions: The midterm follow-up indicated that the simultaneous hybrid revascularization procedure for LMCAD is feasible, safe, and effective. These promising early findings warrant further prospective investigations.
References
Angelini GD, Taylor FC, Reeves BC, Ascione R. 2002. Early and midterm outcome after off-pump and on-pump surgery in Beating Heart against Cardioplegic Arrest Studies (BHACAS 1 and 2): a pooled analysis of two randomised controlled trials. Lancet 359:1194-9.nAngelini GD, Wilde P, Salerno TA, Bosco G, Calafiore AM. 1996. Integrated left small thoracotomy and angioplasty for multivessel coronary artery revascularisation. Lancet 347:757-8.nByrne RA, Kastrati A, Kufner, et al, for the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Investigators. 2009. Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) Trial. Eur Heart J 30:2441-9.nCampeau L, Enjalbert M, Lespérance J, Vaislic C, Grondin CM, Bourassa MG. 1983. Atherosclerosis and late closure of aortocoronary saphenous vein grafts: sequential angiographic studies at 2 weeks, 1 year, 5 to 7 years, and 10 to 12 years after surgery. Circulation 68:II1-7.nChieffo A, Stankovic G, Bonizzoni E, et al. 2005. Early and mid-term results of drug-eluting stent implantation in unprotected left main. Circulation 111:791-5.nFitzgibbon GM, Kafka HP, Leach AJ, Keon WJ, Hooper GD, Burton JR. 1996. Coronary bypass graft fate and patient outcome: angiographic follow-up of 5,065 grafts related to survival and reoperation in 1,388 patients during 25 years. J Am Coll Cardiol 28:616-26.nGao P, Xiong H, Zheng Z, Li L, Gao R, Hu SS. 2010. Evaluation of antiplatelet effects of a modified protocol by platelet aggregation in patients undergoing "one-stop" hybrid coronary revascularization. Platelets 21:183-90.nGrondin CM, Capeau L, Thornton JC, Engle JC, Cross FS, Schreiber H. 1989. Coronary artery bypass grafting with saphenous vein. Circulation 79:I24-9.nKon ZN, Brown EN, Tran R, et al. 2008. Simultaneous hybrid coronary revascularization reduces postoperative morbidity compared with results from conventional off-pump coronary artery bypass. J Thorac Cardiovasc Surg 135:367-75.nMehta RH, Bhatt DL, Steg PG, et al, on behalf of the REACH Registry Investigators. 2008. Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry. Eur Heart J 29:3052-60.nMøller CH, Penninga L, Wetterslev J, Steinbruchel DA, Gluud C. 2008. Clinical outcomes in randomized trials of off- vs. on-pump coronary artery bypass surgery: systematic review with meta-analyses and trial sequential analyses. Eur Heart J 29:2601-16.nNathoe HM, van Dijk D, Jansen EW, et al. 2003. A comparison of on-pump and off-pump coronary bypass surgery in low-risk patients. N Engl J Med 348:394-402.nPatel MR, Dehmer GJ, Hirshfeld JW, Smith PK, Spertus JA. 2009. ACCF/SCAI/STS/AATS/AHA/ASNC 2009 Appropriateness Criteria for Coronary Revascularization: a report by the American College of Cardiology Foundation Appropriateness Criteria Task Force, Society for Cardiovascular Angiography and Interventions, Society of Thoracic Surgeons, American Association for Thoracic Surgery, American Heart Association, and the American Society of Nuclear Cardiology endorsed by the American Society of Echocardiography, the Heart Failure Society of America, and the Society of Cardiovascular Computed Tomography. J Am Coll Cardiol 53:530-53.nPuskas JD, Williams WH, Mahoney EM, et al. 2004. Off-pump vs conventional coronary artery bypass grafting: early and 1-year graft patency, cost, and quality-of-life outcomes: a randomized trial. JAMA 291:1841-9.nReicher B, Poston RS, Mehra MR, et al. 2008. Simultaneous "hybrid" percutaneous coronary intervention and minimally invasive surgical bypass grafting: feasibility, safety, and clinical outcomes. Am Heart J 155:661-7.nRubartelli P, Petronio AS, Guiducci V, et al, for the Gruppo Italiano di Studio sullo Stent nelle Occlusioni Coronariche (GISSOC II) GISE Investigators. 2010. Comparison of sirolimus-eluting and bare metal stent for treatment of patients with total coronary occlusions: results of the GISSOC II-GISE multicentre randomized trial. Eur Heart J 31:2014-20.nZimrin D, Reyes PA, Reicher B, Poston RS. 2007. A hybrid alternative for high risk left main disease. Catheter Cardiovasc Interv 69:123-7.n
